Lack of responsiveness of a nuclear factor-κB-regulated promoter to transactivation by human immunodeficiency virus 1 tat in HeLa cells

Virology

Volumn 263, Issue 1, 1999, Pages 128-138

  Kelly, Gloria D ^a   Morris, Cindy B ^b   Offermann, Margaret K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; GENE INDUCTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033543942     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9966     Document Type: Article

References (38)

1. Albini A., Barillari G., Benelli R., Gallo R. C., Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA. 92:1995;4838-4842.
2. Albini A., Soldi R., Giunciuglio D., Giraudo E., Benelli R., Primo L., Noonan D., Salio M., Camussi G., Rockl W., Bussolino F. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat. Med. 2:1996;1371-1375.
3. Baeuerle P. A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
4. Barillari G., Gendelman R., Gallo R. C., Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA. 90:1993;7941-7945.
5. Beauparlant P., Kwon H., Clarke M., Lin R., Sonenberg N., Wainberg M., Hiscott J. Transdominant mutants of IκBα block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. J. Virol. 70:1996;5777-5785.
6. Benelli R., Mortarini R., Anichini A., Giunciuglio D., Noonan D. M., Montalti S., Tacchetti C., Albini A. Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides. AIDS. 12:1998;261-268.
7. Benkirane M., Chun R. F., Xiao H., Ogryzko V. V., Howard B. H., Nakatani Y., Jeang K. T. Activation of integrated provirus requires histone acetyltransferase: p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273:1998;24898-24905.
8. Berkhout B., Gatignol A., Rabson A. B., Jeang K. T. TAR-independent activation of the HIV-1 LTR: Evidence that tat requires specific regions of the promoter. Cell. 62:1990;757-767.
9. Berkhout B., Jeang K. T. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:1992;139-149.
10. Biswas D. K., Salas T. R., Wang F., Ahlers C. M., Dezube B. J., Pardee A. B. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol. 69:1995;7437-7444.
11. Brake D. A., Debouck C., Biesecker G. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J. Cell Biol. 111:1990;1275-1281.
12. Conant K., Ma M., Nath A., Major E. O. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes. J. Virol. 70:1996;1384-1389.
13. Demarchi F., Di Fagagna F., Falaschi A., Giacca M. Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70:1996;4427-4437.
14. Fan C. M., Maniatis T. Two different virus-inducible elements are required for human beta-interferon gene regulation. EMBO J. 8:1989;101-110.
15. Ganju R. K., Munshi N., Nair B. C., Liu Z. Y., Gill P., Groopman J. E. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72:1998;6131-6137.
16. Garcia J. A., Harrich D., Soultanakis E., Wu F., Mitsuyasu R., Gaynor R. B. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8:1989;765-778.
17. Ghosh S., May M. J., Kopp E. B. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
18. Harhaj E., Blaney J., Millhouse S., Sun S. C. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR. Virology. 216:1996;284-287.
19. Herrmann C. H., Rice A. P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69:1995;1612-1620.
20. Hottinger M. O., Nabel G. J. Interaction of Human Immunodeficiency Virus Type 1 Tat with the Transcriptional Coactivators p300 and CREB Binding Protein. J. Virol. 72:1998;8252-8256.
21. Kelly G., Ensoli B., Gunthel C., Offermann M. Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells. AIDS. 12:1998;1753-1761.
22. Kingston R., Sheen J. Phase extraction assay for CAT activity. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman G. J., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1997;John Wiley & Sons, Inc. New York.
23. Kunsch C., Ruben S. M., Rosen C. A. Selection of optimal kappa B/Rel DNA-binding motifs: Interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:1992;4412-4421.
24. Liu J., Perkins N. D., Schmid R. M., Nabel G. J. Specific NF-κB subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66:1992;3883-3887.
25. Mancebo H. S., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Peng J., Blau C., Hazuda D., Price D., Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:1997;2633-2644.
26. Marzio G., Tyagi M., Gutierrez M. I., Giacca M. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA. 95:1998;13519-13524.
27. Morris G. F., Mathews M. B. The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site. J. Virol. 65:1991;6397-6406.
28. Okamoto T., Wong-Staal F. Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system. Cell. 47:1986;29-35.
29. Olsen H. S., Rosen C. A. Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J. Virol. 66:1992;5594-5597.
30. Peng J., Zhu Y., Milton J. T., Price D. H. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:1998;755-762.
31. Ramazzotti E., Vignoli M., Re M. C., Furlini G., La Placa M. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein. AIDS. 10:1996;455-461.
32. Rice A. P., Carlotti F. Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein. J. Virol. 64:1990a;1864-1868.
33. Rice A. P., Carlotti F. Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins. J. Virol. 64:1990b;6018-6026.
34. Vogel B. E., Lee S. J., Hildebrand A., Craig W., Pierschbacher M. D., Wong-Staal F., Ruoslahti E. A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J. Cell Biol. 121:1993;461-468.
35. Wei P., Garber M. E., Fang S. M., Fischer W. H., Jones K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
36. Westendorp M. O., Shatrov V. A., Schulze-Osthoff K., Frank R., Kraft M., Los M., Krammer P. H., Droge W., Lehmann V. HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:1995;546-554.
37. Yang X., Herrmann C. H., Rice A. P. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70:1996;4576-4584.
38. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M. B., Price D. H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:1997;2622-2632.